These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 35341572)

  • 1. Trace amine-associated receptor 1 and drug abuse.
    Wu R; Liu J; Li JX
    Adv Pharmacol; 2022; 93():373-401. PubMed ID: 35341572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TAAR1 in Addiction: Looking Beyond the Tip of the Iceberg.
    Liu JF; Li JX
    Front Pharmacol; 2018; 9():279. PubMed ID: 29636691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Taar1-mediated modulation of presynaptic dopaminergic neurotransmission: role of D2 dopamine autoreceptors.
    Leo D; Mus L; Espinoza S; Hoener MC; Sotnikova TD; Gainetdinov RR
    Neuropharmacology; 2014 Jun; 81():283-91. PubMed ID: 24565640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TAAR1 and Psychostimulant Addiction.
    Liu J; Wu R; Li JX
    Cell Mol Neurobiol; 2020 Mar; 40(2):229-238. PubMed ID: 31974906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rhesus monkey trace amine-associated receptor 1 signaling: enhancement by monoamine transporters and attenuation by the D2 autoreceptor in vitro.
    Xie Z; Westmoreland SV; Bahn ME; Chen GL; Yang H; Vallender EJ; Yao WD; Madras BK; Miller GM
    J Pharmacol Exp Ther; 2007 Apr; 321(1):116-27. PubMed ID: 17234900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trace amine-associated receptor 1: a multimodal therapeutic target for neuropsychiatric diseases.
    Schwartz MD; Canales JJ; Zucchi R; Espinoza S; Sukhanov I; Gainetdinov RR
    Expert Opin Ther Targets; 2018 Jun; 22(6):513-526. PubMed ID: 29798691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypothesizing that, A Pro-Dopamine Regulator (KB220Z) Should Optimize, but Not Hyper-Activate the Activity of Trace Amine-Associated Receptor 1 (TAAR-1) and Induce Anti-Craving of Psychostimulants in the Long-Term.
    Blum K; Badgaiyan RD; Braverman ER; Dushaj K; Li M; Thanos PK; Demetrovics Z; Febo M
    J Reward Defic Syndr Addict Sci; 2016; 2(1):14-21. PubMed ID: 28317038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Normal thermoregulatory responses to 3-iodothyronamine, trace amines and amphetamine-like psychostimulants in trace amine associated receptor 1 knockout mice.
    Panas HN; Lynch LJ; Vallender EJ; Xie Z; Chen GL; Lynn SK; Scanlan TS; Miller GM
    J Neurosci Res; 2010 Jul; 88(9):1962-9. PubMed ID: 20155805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain-specific overexpression of trace amine-associated receptor 1 alters monoaminergic neurotransmission and decreases sensitivity to amphetamine.
    Revel FG; Meyer CA; Bradaia A; Jeanneau K; Calcagno E; André CB; Haenggi M; Miss MT; Galley G; Norcross RD; Invernizzi RW; Wettstein JG; Moreau JL; Hoener MC
    Neuropsychopharmacology; 2012 Nov; 37(12):2580-92. PubMed ID: 22763617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Role of Biogenic Amine Transporters in Trace Amine-Associated Receptor 1 Regulation of Methamphetamine-Induced Neurotoxicity.
    Miner NB; Phillips TJ; Janowsky A
    J Pharmacol Exp Ther; 2019 Oct; 371(1):36-44. PubMed ID: 31320495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TAAR1 as an emerging target for the treatment of psychiatric disorders.
    Liu J; Wu R; Li JX
    Pharmacol Ther; 2024 Jan; 253():108580. PubMed ID: 38142862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A partial trace amine-associated receptor 1 agonist exhibits properties consistent with a methamphetamine substitution treatment.
    Pei Y; Asif-Malik A; Hoener M; Canales JJ
    Addict Biol; 2017 Sep; 22(5):1246-1256. PubMed ID: 27193165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction Between the Trace Amine-Associated Receptor 1 and the Dopamine D
    Asif-Malik A; Hoener MC; Canales JJ
    Sci Rep; 2017 Oct; 7(1):13901. PubMed ID: 29066851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TAAR1 activation modulates monoaminergic neurotransmission, preventing hyperdopaminergic and hypoglutamatergic activity.
    Revel FG; Moreau JL; Gainetdinov RR; Bradaia A; Sotnikova TD; Mory R; Durkin S; Zbinden KG; Norcross R; Meyer CA; Metzler V; Chaboz S; Ozmen L; Trube G; Pouzet B; Bettler B; Caron MG; Wettstein JG; Hoener MC
    Proc Natl Acad Sci U S A; 2011 May; 108(20):8485-90. PubMed ID: 21525407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential of Ligands for Trace Amine-Associated Receptor 1 (TAAR1) in the Management of Substance Use Disorders.
    Wu R; Li JX
    CNS Drugs; 2021 Dec; 35(12):1239-1248. PubMed ID: 34766253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of trace amine-associated receptor 1 in nicotine's behavioral and neurochemical effects.
    Liu JF; Seaman R; Siemian JN; Bhimani R; Johnson B; Zhang Y; Zhu Q; Hoener MC; Park J; Dietz DM; Li JX
    Neuropsychopharmacology; 2018 Nov; 43(12):2435-2444. PubMed ID: 29472642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trace Amine Associated Receptor 1 (TAAR1) Modulation of Food Reward.
    Moore CF; Sabino V; Cottone P
    Front Pharmacol; 2018; 9():129. PubMed ID: 29535626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective activation of the trace amine-associated receptor 1 decreases cocaine's reinforcing efficacy and prevents cocaine-induced changes in brain reward thresholds.
    Pei Y; Mortas P; Hoener MC; Canales JJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2015 Dec; 63():70-5. PubMed ID: 26048337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trace amine-associated receptor 1 is a modulator of the dopamine transporter.
    Xie Z; Miller GM
    J Pharmacol Exp Ther; 2007 Apr; 321(1):128-36. PubMed ID: 17234899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The selective antagonist EPPTB reveals TAAR1-mediated regulatory mechanisms in dopaminergic neurons of the mesolimbic system.
    Bradaia A; Trube G; Stalder H; Norcross RD; Ozmen L; Wettstein JG; Pinard A; Buchy D; Gassmann M; Hoener MC; Bettler B
    Proc Natl Acad Sci U S A; 2009 Nov; 106(47):20081-6. PubMed ID: 19892733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.